A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma

Chest

Volumn 118, Issue 2, 2000, Pages 313-320

  Peters, Jay I ^a,b   Shelledy, David C ^a   Jones Jr , Arthur P ^a   Lawson, Robert W ^a   Davis, Charles P ^a   LeGrand, Terry S ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Asthma; Salmeterol; agonists

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO; SALBUTAMOL; SALMETEROL XINAFOATE; THEOPHYLLINE;

ADULT; AEROSOL; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033905186     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.2.313     Document Type: Article

References (32)

1. 1 National Institutes of Health. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: US Dept of Health and Human Services; 1997. NIH publication 94-4051
2. 2 Peters JI. Emergency treatment of asthma. Curr Opin Pulm Med 1995; 1:65-72
3. 3 Weiss EB. Status asthmaticus. In: Weiss EB, Segal MS, eds. Bronchial asthma: mechanisms and therapeutics. Boston, MA: Little, Brown, 1976; 875-913
4. 4 Barnes PJ, Pride NG. Dose-response curves to inhaled β-adrenoceptor agonists in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15:677-782
5. 5 Stanescu DC. High doses of sympathomimetics in severe bronchial asthma. Eur Respir J 1989; 2:597-598
6. 6 Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Center, National Asthma Campaign. Guidelines for management of asthma in adults: II. Acute severe asthma. BMJ 1990; 301:797-800
7. 7 Bryant DH, Rogers P. Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma. Chest 1992; 102:742-747
8. 8 Shaheen MJ, Ayres JG, Benincasa C. Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients. Eur Respir J 1994; 7:2160-2164
9. 9 Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and possible development of tachyphylaxis. Am Rev Respir Dis 1990; 142:571-575
10. 10 AAAAI Committee on Drugs. Safety and appropriate use of asthma [editorial]. J Allergy Clin Immunol 1996; 98:475-479
11. 11 British Thoracic Society, Research Unit of the Royal College of Physicians of London. King's Fund Center, et al. Guidelines for management of asthma in adults: I. Chronic persistent asthma. BMJ 1990; 301:651-653
12. 12 Maconochie JG, Forster JK, Fowler P, et al. An initial comparison of salmeterol and salbutamol against histamine-induced bronchoconstriction in health subjects. Br J Pharmacol 1987; 92:749-751
13. 13 Broden RN, Faulds D. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 1991; 42:895-912
14. 14 D'Alonzo GE, Nathan RA, Henochowicz S, et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271:1412-1416
15. 15 Tinkleman DG, Avner SE, Cooper DM. Assessing bronchodilator responsiveness. J Allergy Clin Immunol 1977; 59:109-114
16. 16 Boyd G. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. Eur Respir J 1995; 8:1494-1498
17. 17 Russell G, Williams DAJ, Weller P, et al. Salmeterol xinafoate in children on high dose inhaled steroids. Ann Allergy Asthma Immunol 1995; 75:426-428
18. 18 Faurschou P, Steffensen I, Jacques L. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids: European Respiratory Study Group. Eur Respir J 1996; 9:1885-1890
19. 19 Greening AP, Ind PW, Northfield M, et al. Added salmeterol vs higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid: Allen Hanburys Limited UK Study Group. Lancet 1994; 344:219-224
20. 20 Nicklas RA. Paradoxical bronchospasm associated with the use of inhaled β-agonists. J Allergy Clin Immunol 1990; 85:959-964
21. 21 Nathan RA, Seltzer JM, Kemp JP, et al. Safety of salmeterol in the maintenance treatment of asthma. Ann Allergy Asthma Immunol 1995; 75:243-248
22. 22 Britton MG, Earnshaw JS, Palmer JBD. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992; 5:1062-1067
23. 23 Nelson HS, Szefler MJ, Martin RJ. Regular inhaled β-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental? Am Rev Respir Dis 1991; 144:249-250
24. 24 Castle W, Fuller R, Hall J, et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306:1034-1037
25. 25 Smyth ET, Pavord ID, Wong CS, et al. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ 1993; 306:543-545
26. 26 Kemp JP, Bierman CW, Cocchetto DM. Dose-response study of inhaled salmeterol in healthy subjects. Br J Clin Pharmacol 1994; 37:199-204
27. 27 Charpin D, Beaupre A, Orehek J. Deep-inspiration induced bronchoconstriction: a mechanism for beclomethasone aerosol intolerance. Eur J Respir Dis 1983; 64:494-497
28. 28 Tattersfield AE. Clinical pharmacology of long-acting β-receptor agonists. Life Sci 1993; 42:2161-2169
29. 29 Wilkinson JR, Roberts JA, Bradding P, et al. Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ 1992; 305:931-932
30. 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 1991; 104:665-671
31. 2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43:674-678
32. 32 Campos-Gongora H, Wisniewski A, Tattersfield AE. A single dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis 1991; 144:626-629